Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

Free Abstracts

  Prostate Cancer

  Free Subscription


08.01.2018

1 Anticancer Res
3 BMC Cancer
1 Br J Cancer
2 Br J Radiol
3 Cancer Res
2 Eur Radiol
1 Eur Urol
4 Int J Radiat Oncol Biol Phys
1 J Clin Oncol
1 J Nucl Med
3 J Urol
1 Magn Reson Imaging
6 Mod Pathol
4 Nat Rev Urol
1 PLoS Comput Biol
1 PLoS One
3 Urology


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Anticancer Res

  1. CHANG LW, Hung SC, Hu JC, Chiu KY, et al
    Retzius-sparing Robotic-assisted Radical Prostatectomy Associated with Less Bladder Neck Descent and Better Early Continence Outcome.
    Anticancer Res. 2018;38:345-351.
    PubMed     Text format     Abstract available


    BMC Cancer

  2. HEUMANN A, Heinemann N, Hube-Magg C, Lang DS, et al
    High BCAR1 expression is associated with early PSA recurrence in ERG negative prostate cancer.
    BMC Cancer. 2018;18:37.
    PubMed     Text format     Abstract available

  3. BOTTCHER R, Kweldam CF, Livingstone J, Lalonde E, et al
    Cribriform and intraductal prostate cancer are associated with increased genomic instability and distinct genomic alterations.
    BMC Cancer. 2018;18:8.
    PubMed     Text format     Abstract available

  4. PESTOVA K, Koch AJ, Quesenberry CP, Shan J, et al
    Identification of fluorescence in situ hybridization assay markers for prediction of disease progression in prostate cancer patients on active surveillance.
    BMC Cancer. 2018;18:2.
    PubMed     Text format     Abstract available


    Br J Cancer

  5. MIKROPOULOS C, Selkirk CGH, Saya S, Bancroft E, et al
    Prostate-specific antigen velocity in a prospective prostate cancer screening study of men with genetic predisposition.
    Br J Cancer. 2018 Jan 4. pii: bjc2017429. doi: 10.1038/bjc.2017.
    PubMed     Text format     Abstract available


    Br J Radiol

  6. DENIS-BACELAR AM, Chittenden SJ, McCready VR, Divoli A, et al
    Bone lesion absorbed dose profiles in patients with metastatic prostate cancer treated with molecular radiotherapy.
    Br J Radiol. 2018 Jan 2:20170795. doi: 10.1259/bjr.20170795.
    PubMed     Text format     Abstract available

  7. TEOH EJ, McGowan DR, Schuster DM, Tsakok M, et al
    Bayesian penalised likelihood reconstruction (Q.Clear) of (18)F-fluciclovine PET for imaging of recurrent prostate cancer: semi-quantitative and clinical evaluation.
    Br J Radiol. 2018 Jan 5:20170727. doi: 10.1259/bjr.20170727.
    PubMed     Text format     Abstract available


    Cancer Res

  8. YANG Y, Blee AM, Wang D, An J, et al
    Loss of FOXO1 Cooperates with TMPRSS2-ERG Overexpression to Promote Prostate Tumorigenesis and Cell Invasion.
    Cancer Res. 2017;77:6524-6537.
    PubMed     Text format     Abstract available

  9. COUTURE F, Sabbagh R, Kwiatkowska A, Desjardins R, et al
    PACE4 Undergoes an Oncogenic Alternative Splicing Switch in Cancer.
    Cancer Res. 2017;77:6863-6879.
    PubMed     Text format     Abstract available

  10. EMERSON MA, Banegas MP, Chawla N, Achacoso N, et al
    Disparities in Prostate, Lung, Breast, and Colorectal Cancer Survival and Comorbidity Status among Urban American Indians and Alaskan Natives.
    Cancer Res. 2017 Nov 29. pii: 0008-5472.CAN-17-0429.
    PubMed     Text format     Abstract available


    Eur Radiol

  11. SELNAES KM, Kruger-Stokke B, Elschot M, Willoch F, et al
    (18)F-Fluciclovine PET/MRI for preoperative lymph node staging in high-risk prostate cancer patients.
    Eur Radiol. 2018 Jan 2. pii: 10.1007/s00330-017-5213.
    PubMed     Text format     Abstract available

  12. HANSEN NL, Koo BC, Gallagher FA, Warren AY, et al
    Comparison of initial and tertiary centre second opinion reads of multiparametric magnetic resonance imaging of the prostate prior to repeat biopsy.
    Eur Radiol. 2017;27:2259-2266.
    PubMed     Text format     Abstract available


    Eur Urol

  13. BOSSI A
    Re: Brachytherapy for Patients with Prostate Cancer: American Society of Clinical Oncology/Cancer Care Ontario Joint Guideline Update.
    Eur Urol. 2017 Dec 26. pii: S0302-2838(17)31046.
    PubMed     Text format    


    Int J Radiat Oncol Biol Phys

  14. ROMESSER PB, Pei X, Shi W, Zhang Z, et al
    Prostate-Specific Antigen (PSA) Bounce After Dose-Escalated External Beam Radiation Therapy Is an Independent Predictor of PSA Recurrence, Metastasis, and Survival in Prostate Adenocarcinoma Patients.
    Int J Radiat Oncol Biol Phys. 2018;100:59-67.
    PubMed     Text format     Abstract available

  15. JOHNSTONE E, Wyatt JJ, Henry AM, Short SC, et al
    Systematic Review of Synthetic Computed Tomography Generation Methodologies for Use in Magnetic Resonance Imaging-Only Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2018;100:199-217.
    PubMed     Text format     Abstract available

  16. QIN N, Shen C, Tsai MY, Pinto M, et al
    Full Monte Carlo-Based Biologic Treatment Plan Optimization System for Intensity Modulated Carbon Ion Therapy on Graphics Processing Unit.
    Int J Radiat Oncol Biol Phys. 2018;100:235-243.
    PubMed     Text format     Abstract available

  17. CHI MS, Yang KL, Chang YC, Ko HL, et al
    Comparing the Effectiveness of Combined External Beam Radiation and Hyperthermia Versus External Beam Radiation Alone in Treating Patients With Painful Bony Metastases: A Phase 3 Prospective, Randomized, Controlled Trial.
    Int J Radiat Oncol Biol Phys. 2018;100:78-87.
    PubMed     Text format     Abstract available


    J Clin Oncol

  18. MORGANS AK
    Optimization of Risk Stratification in Localized Prostate Cancer.
    J Clin Oncol. 2018 Jan 5:JCO2017762971. doi: 10.1200/JCO.2017.76.2971.
    PubMed     Text format     Abstract available


    J Nucl Med

  19. CALAIS J, Cao M, Nickols NG
    The Utility of PET/CT in External Radiation Therapy Planning of Prostate Cancer.
    J Nucl Med. 2018 Jan 4. pii: jnumed.117.196444. doi: 10.2967/jnumed.117.196444.
    PubMed     Text format     Abstract available


    J Urol

  20. BERNSTEIN AN, Shoag JE, Golan R, Halpern JA, et al
    Contemporary Incidence & Outcomes of Prostate Cancer Lymph Node Metastases.
    J Urol. 2017 Dec 26. pii: S0022-5347(17)78181-5. doi: 10.1016/j.juro.2017.
    PubMed     Text format     Abstract available

  21. AGHAZADEH MA, Frankel J, Belanger M, McLaughlin T, et al
    NCCN Favorable Intermediate Risk Prostate Cancer Patients: Is Active Surveillance Appropriate?
    J Urol. 2017 Dec 26. pii: S0022-5347(17)78182-7. doi: 10.1016/j.juro.2017.
    PubMed     Text format     Abstract available

  22. OROM H, Biddle C, Underwood W 3rd, Nelson CJ, et al
    Worse urinary, sexual, and bowel function cause emotional distress and vice versa in men treated for prostate cancer.
    J Urol. 2017 Dec 26. pii: S0022-5347(17)78180-3. doi: 10.1016/j.juro.2017.
    PubMed     Text format     Abstract available


    Magn Reson Imaging

  23. RIEDERER SJ, Borisch EA, Froemming AT, Grimm RC, et al
    Improved performance of prostate DCE-MRI using a 32-coil vs. 12-coil receiver array.
    Magn Reson Imaging. 2017 Jan 26. pii: S0730-725X(17)30024.
    PubMed     Text format     Abstract available


    Mod Pathol

  24. EPSTEIN JI
    Prostate cancer grading: a decade after the 2005 modified system.
    Mod Pathol. 2018;31.
    PubMed     Text format     Abstract available

  25. MAGI-GALLUZZI C
    Prostate cancer: diagnostic criteria and role of immunohistochemistry.
    Mod Pathol. 2018;31.
    PubMed     Text format     Abstract available

  26. KRISTIANSEN G
    Markers of clinical utility in the differential diagnosis and prognosis of prostate cancer.
    Mod Pathol. 2018;31.
    PubMed     Text format     Abstract available

  27. RUBIN MA, Demichelis F
    The Genomics of Prostate Cancer: emerging understanding with technologic advances.
    Mod Pathol. 2018;31.
    PubMed     Text format     Abstract available

  28. EVANS AJ
    Treatment effects in prostate cancer.
    Mod Pathol. 2018;31.
    PubMed     Text format     Abstract available

  29. GRIGNON DJ
    Prostate cancer reporting and staging: needle biopsy and radical prostatectomy specimens.
    Mod Pathol. 2018;31.
    PubMed     Text format     Abstract available


    Nat Rev Urol

  30. THOMA C
    Prostate cancer: Pitfalls of liquid biopsy tests.
    Nat Rev Urol. 2018 Jan 3. pii: nrurol.2017.222. doi: 10.1038/nrurol.2017.
    PubMed     Text format    

  31. THOMA C
    Prostate cancer: Utility of ADT during early salvage radiotherapy.
    Nat Rev Urol. 2018 Jan 3. pii: nrurol.2017.226. doi: 10.1038/nrurol.2017.
    PubMed     Text format    

  32. THOMA C
    Prostate cancer: Predicting risk of metastasis after prostatectomy.
    Nat Rev Urol. 2018 Jan 3. pii: nrurol.2017.228. doi: 10.1038/nrurol.2017.
    PubMed     Text format    

  33. STONE L
    Prostate cancer: Rapid testosterone cycling reverses castration resistance.
    Nat Rev Urol. 2018 Jan 3. pii: nrurol.2017.223. doi: 10.1038/nrurol.2017.
    PubMed     Text format    


    PLoS Comput Biol

  34. MARIN DE MAS I, Aguilar E, Zodda E, Balcells C, et al
    Model-driven discovery of long-chain fatty acid metabolic reprogramming in heterogeneous prostate cancer cells.
    PLoS Comput Biol. 2018;14:e1005914.
    PubMed     Text format     Abstract available


    PLoS One

  35. YANG F, Yu N, Wang H, Zhang C, et al
    Downregulated expression of hepatoma-derived growth factor inhibits migration and invasion of prostate cancer cells by suppressing epithelial-mesenchymal transition and MMP2, MMP9.
    PLoS One. 2018;13:e0190725.
    PubMed     Text format     Abstract available


    Urology

  36. HOFER MD, Morey AF, Sheth K, Tausch TJ, et al
    Low Serum Testosterone Level Predisposes to Artificial Urinary Sphincter Cuff Erosion.
    Urology. 2016 Jul 20. pii: S0090-4295(16)30422.
    PubMed     Text format     Abstract available

  37. TANG V, Campbell P, Pattison DA
    Lymphangitic Carcinomatosis From Prostate Cancer Identified with Gallium-68 Prostate-Specific Membrane Antigen Positron Emission Tomography Imaging.
    Urology. 2017 Dec 29. pii: S0090-4295(17)31327.
    PubMed     Text format     Abstract available

  38. WALLIS CJD, Satkunasivam R, Herschorn S, Law C, et al
    Association between Primary Local Treatment and Non-Prostate Cancer Mortality in Men with Non-Metastatic Prostate Cancer.
    Urology. 2018 Jan 2. pii: S0090-4295(17)31330.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Prostate Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: